FLT3 and acute myeloid leukemia: No significant differences were observed in variables such as age at diagnosis, gender, FAB subtypes (The French-American-British classification of AML), or other clinical data between FLT3 mutant and wild-type groups (Fig. 1A and Supplementary File 2).